Stoke TherapeuticsNASDAQ: STOK: Develops RNA-based therapies for severe genetic disorders.
10+ YOE5+ Mgmt10+ years CMC experience with drug-device combination products, 5+ years CMC leadership, bachelor's required (advanced degree preferred), deep CMC/regulatory knowledge, strong communication and cross-functional leadership.
Rhythm PharmaceuticalsNASDAQ: RYTM: Develops precision medicines for rare neuroendocrine and obesity diseases.
10+ YOEBS in life sciences, 10+ years regulatory CMC or related pharma experience, experience with peptides and injectable dosage forms, ability to author CMC submissions and coordinate cross-functional inputs.
Genetix Biotherapeutics: Developing and commercializing curative gene therapies for rare diseases.
10+ YOE10+ years biopharma CMC regulatory experience for biologics/gene therapies; bachelor’s or master’s in life sciences; experience with post-approval CMC submissions, GMP and global regulatory frameworks; strong communication and cross-functional skills.
SanofiEuronext Paris: SAN: Researches, develops, and manufactures medicines and vaccines globally.
5+ YOEPhD or MS in pharmaceutical-related field; minimum 5 years CMC development experience; proven CMC dossier authoring; knowledge of regulatory and digital transformation in pharma; leadership and collaboration skills; Vault RIM, Word and Adobe proficiency.
New York City or Salt Lake City or London or Montréal or Milton Park or Boston or San Francisco
$208k-$281k/yrRemoteFull Time
RecursionNASDAQ: RXRX: Developing medicines using an AI-native drug discovery platform.
8+ YOE8+ years CMC regulatory experience for small molecules, BA/BS or advanced degree, RAC preferred, deep knowledge of US, EU and ex-US CMC regulations, track record authoring INDs/NDAs, cross-functional collaboration.
Vor BioNASDAQ: VOR: Developing targeted therapies for chronic autoimmune diseases.
8+ YOEDoctorate preferred; ≥8 years Regulatory CMC biologics experience with FDA sCDER interactions, global submissions, lifecycle management, and biologics/combination product development.
AbbVieNYSE: ABBV: Develops and sells innovative pharmaceutical and biopharmaceutical medicines.
10+ YOE3+ MgmtBachelor's in pharmacy/biology/chemistry/engineering required; 10+ years biopharma experience with 3+ years enterprise leadership and 5+ years RA exposure; experience developing global regulatory CMC strategies and interfacing with agencies.
ModernaNasdaq: MRNA: Develops and manufactures messenger RNA medicines and vaccines.
15+ YOEDegree in life sciences or related field, 15 years relevant experience (or 10 years with PhD), deep stability science and CMC judgment, experience with stability strategy, regulatory submissions, leadership and cross-functional collaboration.
Xenon PharmaceuticalsNASDAQ: XENE: Developing therapeutics for neurological and psychiatric disorders.
10+ YOEPhD in Chemistry or Chemical Engineering with 10+ years API CDMO experience; regulatory CMC writing; CDMO selection and tech transfer; extensive cGMP knowledge.
CRISPR TherapeuticsNASDAQ: CRSP: Develops gene-editing medicines using the CRISPR/Cas9 platform.
12+ YOEBachelor's in relevant science required; 12+ years regulatory CMC experience (10+ with advanced degree); direct CMC experience for biologics/cell & gene therapies; knowledge of FDA/EMA/ICH and eCTD submissions.
Oruka TherapeuticsNASDAQ: ORKA: Develops long-acting biologics for chronic skin and inflammatory diseases.
6+ YOEMaster's or PhD in life sciences, 6+ years CMC experience with minimum 3+ years regulatory CMC in biologics, cGMP and global regulatory submission expertise (FDA/EMA/ICH), experience authoring Module 3 and combination product submissions.
Madrigal PharmaceuticalsNASDAQ: MDGL: Develops and commercializes therapeutics for metabolic dysfunction-associated steatohepatitis.
12+ YOEBS in life sciences or equivalent experience (advanced degree preferred); minimum 12 years relevant experience with 8-10 years regulatory CMC experience; strategic CMC regulatory expertise; experience with global health authorities; strong communication and negotiation skills.
Crescent BiopharmaNASDAQ: CBIO: Develops novel oncology therapies and antibody-drug conjugates for cancer.
5+ YOEBachelor's degree required; 5+ years biotech/pharma experience in CMC/Technical Operations or project management; familiarity with GMP, external partner management, risk identification, and cross-functional coordination.
Cambridge or Research Triangle Park or San Francisco
$204k-$281k/yrHybridFull Time
BiogenNASDAQ: BIIB: Develops therapies for neurological and neurodegenerative diseases.
12+ YOE12+ years' experience in matrix leadership with CMC/supply chain or life cycle management; BS required, advanced degree preferred; alliance and financial management experience; strong strategic, communication and risk-management skills.
Associate Director / Director, CMC Project Management
Waltham, Massachusetts, United States
$220k-$245k/yrOnsiteFull Time
Korsana BiosciencesNASDAQ: CYCN: Develops novel therapies to treat neurodegenerative diseases.
8+ YOE5+ MgmtBachelor's in a scientific field required (advanced preferred); 8+ years biotech/pharma experience with ≥5 years CMC project management; experience with biologics, CDMOs, regulatory CMC familiarity; strong project and stakeholder management skills.
Sionna TherapeuticsNASDAQ: SION: Developing small molecule medicines to treat cystic fibrosis.
12+ YOEBachelor's in a scientific discipline required (advanced degree preferred). 12+ years Regulatory Affairs with hands-on CMC leadership across clinical through registration; experience with small-molecule NCEs, regulatory submissions, health authority meetings, and Veeva required.
MerckXETRA: MRK: A science and technology providing healthcare, life science, and electronics solutions.
1+ YOEBachelor's degree in life science,1+ years pharmaceutical or academic experience with regulatory/CMC knowledge,ability to develop CMC strategies and prepare CMC dossiers.
Beam TherapeuticsNASDAQ: BEAM: Develops precision genetic medicines using base editing technology.
10+ YOEAdvanced degree in life sciences or engineering,10+ years CMC development experience with leadership, expertise in nucleic acid/LNP manufacturing and analytics, regulatory submission experience, strong risk management and communication skills.
Alnylam PharmaceuticalsNASDAQ: ALNY: Develops RNAi therapeutics to treat rare and common diseases.
8+ YOEAdvanced degree in a relevant scientific discipline, 8+ years industry experience including 5+ years in Regulatory Affairs CMC, experience with regulatory submissions and health authority interactions, strong communication and cross-functional leadership.